Patents by Inventor Kenneth Stauderman

Kenneth Stauderman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240307384
    Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.
    Type: Application
    Filed: March 1, 2024
    Publication date: September 19, 2024
    Inventors: Gonul VELICELEBI, Kenneth STAUDERMAN, Michael DUNN, Jack ROOS
  • Publication number: 20240010638
    Abstract: Provided herein is an improved synthetic method for the production of CRAC channel inhibitors. The synthetic method provides a method for producing highly pure CRAC channel inhibitors for clinical testing.
    Type: Application
    Filed: November 13, 2020
    Publication date: January 11, 2024
    Inventors: Kenneth STAUDERMAN, Michael DUNN, Kay OLMSTEAD
  • Patent number: 11752148
    Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: September 12, 2023
    Assignee: CALCIMEDICA, INC.
    Inventors: Gonul Velicelebi, Kenneth Stauderman, Michael Dunn, Jack Roos
  • Patent number: 11439639
    Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.
    Type: Grant
    Filed: September 10, 2021
    Date of Patent: September 13, 2022
    Assignee: CALCIMEDICA, INC.
    Inventors: Gonul Velicelebi, Kenneth Stauderman, Michael Dunn, Jack Roos
  • Publication number: 20220265645
    Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may he used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.
    Type: Application
    Filed: March 16, 2021
    Publication date: August 25, 2022
    Inventors: Gonul VELICELEBI, Kenneth STAUDERMAN, Michael DUNN, Jack ROOS
  • Patent number: 11311535
    Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: April 26, 2022
    Assignee: CALCIMEDICA, INC.
    Inventors: Gonul Velicelebi, Kenneth Stauderman, Michael Dunn, Jack Roos
  • Publication number: 20220000863
    Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.
    Type: Application
    Filed: September 10, 2021
    Publication date: January 6, 2022
    Inventors: Gonul VELICELEBI, Kenneth STAUDERMAN, Michael DUNN, Jack ROOS
  • Patent number: 11013737
    Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.
    Type: Grant
    Filed: October 22, 2020
    Date of Patent: May 25, 2021
    Assignee: CALCIMEDIA, INC.
    Inventors: Gonul Velicelebi, Kenneth Stauderman, Michael Dunn, Jack Roos
  • Patent number: 10973818
    Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.
    Type: Grant
    Filed: October 22, 2020
    Date of Patent: April 13, 2021
    Assignee: CALCIMEDICA, INC.
    Inventors: Gonul Velicelebi, Kenneth Stauderman, Michael Dunn, Jack Roos
  • Publication number: 20210038597
    Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.
    Type: Application
    Filed: October 22, 2020
    Publication date: February 11, 2021
    Inventors: Gonul VELICELEBI, Kenneth STAUDERMAN, Michael DUNN, Jack ROOS
  • Publication number: 20200368228
    Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.
    Type: Application
    Filed: August 7, 2020
    Publication date: November 26, 2020
    Inventors: Gonul VELICELEBI, Kenneth STAUDERMAN, Michael DUNN, Jack ROOS
  • Patent number: 10821109
    Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: November 3, 2020
    Assignee: CALCIMEDICA, INC.
    Inventors: Gonul Velicelebi, Kenneth Stauderman, Michael Dunn, Jack Roos
  • Publication number: 20200101069
    Abstract: Described herein are methods of treatment of stroke and traumatic brain injury comprising administration of a CRAC channel inhibitor.
    Type: Application
    Filed: August 8, 2019
    Publication date: April 2, 2020
    Inventors: Kenneth STAUDERMAN, Michael DUNN, Sudarshan HEBBAR, Midori YENARI, Rachid KACIMI
  • Patent number: 10478435
    Abstract: Described herein are methods of treatment of stroke and traumatic brain injury comprising administration of a CRAC channel inhibitor.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: November 19, 2019
    Assignees: CALCIMEDICA, INC., THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Kenneth Stauderman, Michael Dunn, Sudarshan Hebbar, Midori Yenari, Rachid Kacimi
  • Patent number: 10420766
    Abstract: Described herein are methods of treatment of stroke and traumatic brain injury comprising administration of a CRAC channel inhibitor.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: September 24, 2019
    Assignees: CALCIMEDICA, INC., THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Kenneth Stauderman, Michael Dunn, Sudarshan Hebbar, Midori Yenari, Rachid Kacimi
  • Publication number: 20180235959
    Abstract: Described herein are methods of treatment of stroke and traumatic brain injury comprising administration of a CRAC channel inhibitor.
    Type: Application
    Filed: August 5, 2016
    Publication date: August 23, 2018
    Inventors: Kenneth STAUDERMAN, Michael DUNN, Sudarshan HEBBAR, Midori YENARI, Rachid KACIMI
  • Publication number: 20180235958
    Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.
    Type: Application
    Filed: February 26, 2016
    Publication date: August 23, 2018
    Inventors: Gonul VELICELEBI, Kenneth STAUDERMAN, Michael DUNN, Jack ROOS
  • Publication number: 20070031814
    Abstract: Methods are provided for identifying agents that modulate intracellular calcium. Also provided are methods of modulating calcium within cells and methods of identifying proteins involved in modulating intracellular calcium.
    Type: Application
    Filed: March 3, 2004
    Publication date: February 8, 2007
    Inventors: Jack Roos, Kenneth Stauderman, Gonul Velicelebi, Paul Digregorio, Kari Ohlsen
  • Publication number: 20040009537
    Abstract: Methods are provided for identifying agents that modulate intracellular calcium. Also provided are methods of modulating calcium within cells and treating disease by modulating intracellular calcium. Also provided are methods of screening for nucleic acids encoding candidate ion transport proteins and methods of identifying nucleic acids encoding ion transport proteins.
    Type: Application
    Filed: January 13, 2003
    Publication date: January 15, 2004
    Inventors: Jack Roos, Kenneth Stauderman, Gonul Velicelebi